[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100585855":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":35,"responsibleParty":53,"collaborators":55,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":65,"acronym":29,"eligibilityCriteria":66,"healthyVolunteers":63,"sex":67,"minAge":68,"maxAge":29,"enrollmentInfo":69,"targetDuration":29,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":79,"overallStatus":37,"whyStopped":29,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"TRIAL Web-Based Application","EXPERIMENTAL","Enrolled participants will complete:\n\n* Baseline visit and questionnaires\n* Access to web application over the course of 14 days.\n* End of study questionnaires\n* 12 participants will take part in semi-structured interviews with study staff which will be audio recorded.",[13],"Behavioral: TRIAL Web-Based Application",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"BEHAVIORAL","A web-based application that provides disease and trial education and access to resources provided by the Leukemia and Lymphoma Society (LLS). iPads will be provided to participants for 14 days.",[9],[20],"TRIAL",[22],{"name":23,"affiliation":5,"role":24},"Andrew Hantel, MD","PRINCIPAL_INVESTIGATOR",[26,31],{"name":23,"role":27,"phone":28,"phoneExt":29,"email":30},"CONTACT","617-582-9394",null,"Andrew_hantel@dfci.harvard.edu",{"name":32,"role":27,"phone":33,"phoneExt":29,"email":34},"Erin Gallagher","857-215-2275","erin_gallagher@dfci.harvard.edu",[36],{"facility":5,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","Boston","Massachusetts","02215","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-71.05977,42.35843,{"lat":47,"lon":46},[50,52],{"name":23,"role":27,"phone":28,"phoneExt":29,"email":51},"Andrew_Hantel@dfci.harvard.edu",{"name":23,"role":24,"phone":29,"phoneExt":29,"email":29},{"type":24,"investigatorFullName":23,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":29,"oldOrganization":29},"Principal Investigator",[56,58],{"name":57,"class":6},"American Society of Clinical Oncology",{"name":59,"class":60},"National Cancer Institute (NCI)","NIH","100585855","tools-for-reducing-inequity-in-acute-leukemia-trial-beta-testing-100585855",false,"NCT06907797","Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing","Inclusion Criteria:\n\n* Age 18 or older\n* English speaking\n* Ability to understand and willingness to sign written informed consent\n* Clinical suspicion of acute leukemia\n* Admitted to DFCI-affiliated inpatient unit\n\nExclusion Criteria:\n\n* Cognitive impairment rendering the individual unable to participate in beta testing\n\n  * This will be assessed by focused chart review and consultation with the patients' inpatient care team.\n* The following populations will be excluded: adults unable to consent, individuals who are not yet adults (infants, children, teenagers \\\u003C18 years old), prisoners.\n* Inability to participate in in-person application testing.\n* Patients who participated in alpha-testing through protocol 23-404 (Appendix A)","ALL","18 Years",{"count":70,"type":71},75,"ESTIMATED","INTERVENTIONAL",[74],"NA","This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.",[77,78],"Acute Leukemia","Leukemia",[77,78],"2026-05-18",{"date":82,"type":83},"2026-05-20","ACTUAL",{"date":85,"type":83},"2025-04-01",{"date":87,"type":71},"2027-06-30",{"name":5,"class":6},1]